Cellfree DNA levels during deliveries at term and preterm - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

Cellfree DNA levels during deliveries at term and preterm

Description:

Sandra Majer, Eva Magnet, Margit Bauer, Wolfgang Sch ll, Andrea Strele, Uwe Lang ... Strongest risk factor: maternal or fetal ... Farina et al (2005) ... – PowerPoint PPT presentation

Number of Views:35
Avg rating:3.0/5.0
Slides: 13
Provided by: lkhunivkli
Category:

less

Transcript and Presenter's Notes

Title: Cellfree DNA levels during deliveries at term and preterm


1
Cell-free DNA levels during deliveries at term
and preterm
  • Sandra Majer, Eva Magnet, Margit Bauer, Wolfgang
    Schöll, Andrea Strele, Uwe Lang and Barbara Pertl
  • Department of Obstetrics and Gynecology
  • Medical University of Graz
  • Austria

2
Preterm birth (Delivery before 37th week of
gestation)
  • Risk factors
  • Strongest risk factor maternal or fetal
    predisposition women born preterm
  • Previous preterm deliveries
  • Genotype of immunoregulatory genes
  • Malformation of the uterus
  • Infections during pregnancies
  • Twin pregnancies
  • Maternal age

3
Cell-free fetal DNA and preterm deliveries
  • Leung et al. (1998) cell-free fetal DNA
    (cff-DNA) levels were increased in women who
    delivered preterm compared to women with preterm
    labor and final delivery at term

4
Cff-DNA as risk factor for spontaneous preterm
deliveries
  • Farina et al (2005)
  • High concentrations of cff-DNA in maternal serum
    were associated with an increased risk of
    spontaneous preterm deliveries
  • The cumulative rate of early preterm delivery
    (lt30 week of gestation) was significantly higher
    for women with cff-DNA concentrations of 1.82
    multiples of the median than those with
    concentrations below this cut-off (P0.008)

5
Cff-DNA during labor at term
  • Ingargiola et al., (2003) determined the cff-DNA
    levels during vaginal deliveries at term
  • Serially every hour and one hour after delivery
    venous blood samples, induction of labor
  • Could not demonstrate any changes during labor
  • No effect on fetal DNA release at term

6
Aim of the study
  • cff-DNA levels a marker for preterm birth?
  • Aim of our study
  • to evaluate cff- and total DNA levels during
    deliveries (vaginal and cesarean section) at term
    and preterm
  • to compare the cff- and total DNA levels between
    deliveries at term and preterm

7
Study design I
  • Venous blood samples were serially collected
    every two hours during delivery and a final ones
    two hours postpartum from 27 women pregnant with
    male fetuses.
  • 18 women delivered at term (37th to 41st week of
    gestation)
  • 9 delivered preterm (24th to 36th week of
    gestation).
  • Controls
  • 15 women pregnant with female fetuses (33rd to
    42nd week of gestation)
  • 148 pregnant women without labor

8
Study design II
  • The amount of cff-DNA was determined by
    quantitative real-time PCR using the SRY-assay
    and the total DNA was determined using the
    ß-Globin-assay
  • Statistical analysis Mann Whitney-Test

9
Results I
  • Cff-DNA levels are significantly increased during
    spontaneous deliveries at term compared to
    spontaneous preterm deliveries with uterine
    contraction (plt0.01)
  • Cff-DNA levels are significantly increased during
    deliveries at term compared to cesarean sections
    without any uterine contraction (plt0.05)

10
Results II
  • In contrast to the published data by Ingargiola
    et al. (2003), the cff-DNA levels were
    significantly increased in pregnant women during
    labor when compared to pregnant women without
    labor at term (37th to 42nd week of gestation)
    (p0.014)
  • No significant difference was found in the
    cff-DNA levels at different times of blood
    collection during labor
  • No significant difference was determined in the
    total DNA levels during deliveries at term and
    preterm
  • No SRY-specific DNA was found in the 15 plasma
    samples obtained from women pregnant with female
    fetuses

11
Future plans
  • To increase the sample size
  • To collect and analyze blood samples from
    pregnant women in second trimester of gestation
    as controls
  • To analyse samples of pregnant women with PROM,
    chorioamnionitis, etc

12
Thanks to
  • SAFE-Network
  • Medical University of Graz
  • Center for Medical Research
  • for financial support
Write a Comment
User Comments (0)
About PowerShow.com